Detalhe da pesquisa
1.
Motor neuron loss in SMA is not associated with somal stress-activated JNK/c-Jun signaling.
Hum Mol Genet
; 28(19): 3282-3292, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31272106
2.
HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease.
Brain
; 141(3): 673-687, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29415205
3.
A dominant mutation in FBXO38 causes distal spinal muscular atrophy with calf predominance.
Am J Hum Genet
; 93(5): 976-83, 2013 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24207122
4.
HDAC6 at the Intersection of Neuroprotection and Neurodegeneration.
Traffic
; 13(6): 771-9, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22372633
5.
Regulation of human microglial gene expression and function via RNAase-H active antisense oligonucleotides in vivo in Alzheimer's disease.
Mol Neurodegener
; 19(1): 37, 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38654375
6.
Small heat-shock protein HSPB1 mutants stabilize microtubules in Charcot-Marie-Tooth neuropathy.
J Neurosci
; 31(43): 15320-8, 2011 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-22031878
7.
Missing lnc(RNAs) in Alzheimer's Disease?
Genes (Basel)
; 13(1)2021 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35052379
8.
From Junk to Function: LncRNAs in CNS Health and Disease.
Front Mol Neurosci
; 14: 714768, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34349622
9.
Effects of mental stress on autonomic cardiac modulation during weightlessness.
Am J Physiol Heart Circ Physiol
; 298(1): H202-9, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19897707
10.
Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment.
J Clin Invest
; 129(11): 4817-4831, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31589162
11.
Genetically Engineered iPSC-Derived FTDP-17 MAPT Neurons Display Mutation-Specific Neurodegenerative and Neurodevelopmental Phenotypes.
Stem Cell Reports
; 11(2): 363-379, 2018 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30057263
12.
The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy.
Neuron
; 93(1): 66-79, 2017 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28017471
13.
Spinal Muscular Atrophy Therapeutics: Where do we Stand?
Neurotherapeutics
; 12(2): 303-16, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25631888
14.
Genetically Engineered iPSC-Derived FTDP-17 MAPT Neurons Display Mutation-Specific Neurodegenerative and Neurodevelopmental Phenotypes.
Stem Cell Reports
; 13(2): 434-435, 2019 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31412287
15.
Charcot-Marie-Tooth disease: emerging mechanisms and therapies.
Int J Biochem Cell Biol
; 44(8): 1299-304, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22575637
16.
HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease.
Nat Med
; 17(8): 968-74, 2011 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21785432